New Delhi, Jan. 27, 2025 (GLOBE NEWSWIRE) -- According to Astute Analytica’s latest market analysis, the Japan pharmaceutical manufacturing market was valued at US$ 34.7 billion in 2024 and is ...

New Delhi, Jan. 27, 2025 (GLOBE NEWSWIRE) -- According to Astute Analytica’s latest market analysis, the Japan pharmaceutical manufacturing market was valued at US$ 34.7 billion in 2024 and is ...

A major Japanese pharmaceutical company that offers therapies for rare diseases and operates around the globe has opened an ...

TOKYO (Kyodo) -- Japanese pharmaceutical company Eisai Co. and U.S. firm Biogen Inc. said Monday that a jointly developed Alzheimer's drug has been approved for continuous use for people with ...

Oral mucositis is a painful condition in which the mucous membranes inside the mouth become inflamed. To help alleviate this, ...

However, only the Japanese pharmaceutical company KM Biologics Co., based in Kumamoto, produces vaccines that can also be given to children. Congo has requested the vaccines from the company.

“This initiative will up-level the Japanese pharmaceutical industry with high performance computing and unlock the potential of generative AI to discover new therapies," Makiguchi adde ...

has created new business opportunities for Japanese pharmaceutical companies. Now, innovative businesses are investing heavily in research that is changing how people around the world take their ...

By 2008, they had sold their stake in Ranbaxy to Japanese pharmaceutical giant Daiichi Sankyo for $4.6 billion. However, just six months later, Daiichi wrote off the entire investment after the US ...

TOKYO -- Japan's Takeda Pharmaceutical announced on Thursday that CEO Christophe Weber will step down in June 2026 and be succeeded by current U.S. business head Julie Kim, who would become the ...

The Japanese pharmaceutical company Kyowa Kirin Co. plans to sell shares in the Chinese division of the Hong Kong company WinHealth Pharma Group Co. for 15 billion yen ($100 million) as part of the ...

The Japanese drugmaker said that Kim, president of its U.S. business unit, will succeed Chief Executive Christophe Weber, who ...